These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 16387851)
1. Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia. Morris JC; Janik JE; White JD; Fleisher TA; Brown M; Tsudo M; Goldman CK; Bryant B; Petrus M; Top L; Lee CC; Gao W; Waldmann TA Proc Natl Acad Sci U S A; 2006 Jan; 103(2):401-6. PubMed ID: 16387851 [TBL] [Abstract][Full Text] [Related]
2. Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP. Enose-Akahata Y; Oh U; Ohayon J; Billioux BJ; Massoud R; Bryant BR; Vellucci A; Ngouth N; Cortese I; Waldmann TA; Jacobson S Ann Clin Transl Neurol; 2019 Aug; 6(8):1383-1394. PubMed ID: 31402625 [TBL] [Abstract][Full Text] [Related]
3. Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia. Waldmann TA; Conlon KC; Stewart DM; Worthy TA; Janik JE; Fleisher TA; Albert PS; Figg WD; Spencer SD; Raffeld M; Decker JR; Goldman CK; Bryant BR; Petrus MN; Creekmore SP; Morris JC Blood; 2013 Jan; 121(3):476-84. PubMed ID: 23212516 [TBL] [Abstract][Full Text] [Related]
4. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction. Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399 [TBL] [Abstract][Full Text] [Related]
5. [Interleukin 2 (IL-2) and its receptor (IL-2R) in healthy individuals and with various disease states]. Mazur G; Frydecka I Acta Haematol Pol; 1993; 24(4):307-13. PubMed ID: 8303976 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells. Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656 [TBL] [Abstract][Full Text] [Related]
7. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor. Azimi N; Jacobson S; Leist T; Waldmann TA J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011 [TBL] [Abstract][Full Text] [Related]
8. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts. Waldmann TA; Goldman CK Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757 [TBL] [Abstract][Full Text] [Related]
9. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy. Waldmann TA Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734 [TBL] [Abstract][Full Text] [Related]
10. T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma. Waldmann TA Ann Oncol; 2000; 11 Suppl 1():101-6. PubMed ID: 10707789 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of interleukin 4 on production of interleukin 6 by adult T-cell leukemia cells. Mori N; Shirakawa F; Murakami S; Oda S; Eto S Cancer Res; 1993 Oct; 53(19):4643-7. PubMed ID: 8402641 [TBL] [Abstract][Full Text] [Related]
16. 1992 Stohlman Memorial Lecture: targeting the IL-2 receptor. Waldmann TA Leukemia; 1993 Aug; 7 Suppl 2():S151-6. PubMed ID: 8361223 [TBL] [Abstract][Full Text] [Related]
17. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia. Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338 [TBL] [Abstract][Full Text] [Related]
18. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor--a model for human T-cell malignancies expressing IL-2 receptor. Lugasi H; Hajos S; Murphy JR; Strom TB; Nichols J; Peñarroja C; Naor D Int J Cancer; 1990 Jan; 45(1):163-7. PubMed ID: 2298500 [TBL] [Abstract][Full Text] [Related]
19. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor. Yoon HJ; Sugamura K; Loughran TP Leukemia; 1990 Dec; 4(12):848-50. PubMed ID: 2147047 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia. Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]